(NASDAQ: ETNB) couldn't quite keep pace with the broader stock market on Tuesday. Investors were hesitant to buy shares of ...

ContentsUS exits Paris Agreement againAre biofuels subsidies at risk?Buffer factors: Republicans could ringfence biofuelsWhy ...

There is a need for nuanced immigration policies that emphasise the complementary relationship between foreign talent and ...

Akero Therapeutics reports a 39% improvement in cirrhosis patients using EFX. See why AKRO stock is soaring with the ...

With such volatility, SLXN has emerged as one of the most talked-about stocks of the day, creating a buzz in the biotechnology sector. Let’s dive into the details behind this remarkable movement and ...

Investors often prefer to invest in shares held by company insiders, as management is typically more aligned with the company’s success and shareholder interests. Currently, insiders own just 45.04% ...

Following a lawsuit filed last week, Sage has officially rejected Biogen’s unsolicited buyout offer, which valued the ...

Reliever Tanner Scott’s $72 million, four-year contract with the Los Angeles Dodgers includes $21 million in deferred ...

If the 118th Congress does not reauthorize the farm bill, it will be incumbent upon the 119 th Congress to pass an updated ...

Retro Biosciences will back clinical trials for three drugs—including a potential Alzheimer’s disease treatment set to begin ...

Chris Viehbacher spoke out about the uncertain policy environment for life sciences companies, though he didn't single ...